Medical Devices

GE's new Allia upgrade pathways offer a lifeline to hospitals, blending AI innovation with fiscal and environmental responsibility. Is this the future of MedTech?

CraniUS Therapeutics secures up to $4M in NIH funding for its NeuroPASS device, a refillable implant aiming to revolutionize glioblastoma and CNS treatment.

A landmark real-world study shows an 83.5% response rate for PTSD in patients with comorbid depression, signaling a potential paradigm shift for a notoriously hard-to-treat population.

With FDA clearance and strategic provincial funding, Conavi Medical's dual-imaging system isn't just a new device; it's a new playbook for medtech.

Smartee Denti-Technology is moving beyond simple teeth straightening, launching tech for complex jaw issues and sleep apnea while building a European empire.

A Pennsylvania firm's new 3D-printed titanium cervical cage has been used in a patient for the first time, heralding a new era of spinal implants.

As pharma giants battle with blockbuster drugs, one company is betting on a simple, non-systemic hydrogel. Is this the future of weight management?

With its Saber-C system surpassing 5,000 implantations, Elevation Spine is validating a new approach that streamlines one of surgery's most common procedures.

Shore Medical Center is the first in NJ to adopt the VELYS™ Spine robot. We dig into the tech, the strategy, and what it means for healthcare's future.

French med-tech firm IMPLANET is using strategic sponsorships and key partnerships to challenge giants in the $14B spinal device market. Here's the bottom line.

At the University of Miami, 3D anatomical avatars are changing doctor visits. This tech promises clarity, but what are the hidden costs of progress?

With a third of its population to be over 65 by 2046, Hong Kong’s tech and home industries are pivoting. The In-Home Expo showcases the AI-driven future.

A medical imaging firm and a South African gas project merge in a bold, complex deal. Will this unlikely union unlock critical helium supplies or just dilute value?

A new wearable from NeuroLife promises to personalize stroke and spinal cord injury rehab. Can this non-invasive sleeve bridge the gap in accessible care?

Nanox reports revenue growth but a shrinking cash pile and a stark warning about its future, forcing a strategic retreat from guidance amid legal troubles.

As Abbott prepares its July 16th earnings report, all eyes are on more than just the balance sheet. It's a test of its post-acquisition strategy.

A new partnership promises a less painful way to deliver cancer immunotherapy. We dive into the tech, the market, and why this is a key strategic play.

As the GLP-1 market booms, Vivani Medical's new semaglutide implant promises a 'set-and-forget' solution to the adherence crisis plaguing weight-loss drugs.

With its stock lagging despite strong sales, Insulet brings on a proven value-creator. Can the 'Mazelsky Playbook' accelerate growth and fend off rivals?